Expression of both ESRRA and PPARGC1A was suppressed in TIRM+ muscle compared to control (Fig. 3C and D), confirming our in vitro findings [69] in FSHD patients. Here, ESRRA is linked to facioscapulohumeral muscular dystrophy.